TG Therapeutics

is a biopharmaceutical company focused on the development of
novel treatments for B-cell malignancies and autoimmune diseases.

 

Click for full image >>

For Investors

NASDAQ: TGTX
Stock Quote at: May 25, 4:00PM EDT

Last: $11.90

Change: $0.05 (0.42%)

Quotes provided by Google - Min 15 minute delay